Medical Developments International (ASX:MVP) Gross-Profit-to-Asset % : 47.29% (As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Medical Developments International's annualized Gross Profit for the quarter that ended in Dec. 2024 was A$29.44 Mil. Medical Developments International's average Total Assets over the quarter that ended in Dec. 2024 was A$62.25 Mil. Therefore, Medical Developments International's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 47.29%.

Medical Developments International Gross-Profit-to-Asset % Historical Data

The historical data trend for Medical Developments International's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International Gross-Profit-to-Asset % Chart

Medical Developments International Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

17.68

20.65

16.25

22.78

30.37

Medical Developments International Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															19.66	23.11	22.88	35.58	47.29

Competitive Comparison of Medical Developments International's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Developments International's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Medical Developments International's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Medical Developments International Gross-Profit-to-Asset % Calculation

Medical Developments International's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2024 )	/	( (Total Assets (A: Jun. 2023 )	+	Total Assets (A: Jun. 2024 ))	/ count )
	=	24.366	/	( (101.313	+	59.161)	/ 2 )
	=	24.366	/	80.237
	=	30.37 %

Medical Developments International's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	29.438	/	( (59.161	+	65.331)	/ 2 )
	=	29.438	/	62.246
	=	47.29 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Medical Developments International Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Medical Developments International's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Developments International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

MDDVF:USA

Address

4 Caribbean Drive, Scoresby, VIC, AUS, 3179

Website

https://www.medicaldev.com

Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire • 03-18-2022

Medical Developments International Stock Appears To Be Possible Value Trap

By GF Value • 01-01-1970